Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
In 1986, Kärre and colleagues reported that natural killer (NK) cells rejected an MHC class I-deficient tumor cell line (RMA-S) but they did not reject the same cell line if it expressed MHC class I (RMA). Based on this observation, they proposed the concept that NK cells provide immune surveillance for “missing self,” e.g., they eliminate cells that have lost class I MHC antigens. This seminal observation predicted the existence of inhibitory NK cell receptors for MHC class I. Here, we present evidence that NK cells are able to reject tumors expressing MHC class I if the tumor expresses a ligand for NKG2D. Mock-transfected RMA cells resulted in tumor formation. In contrast, when RMA cells were transfected with the retinoic acid early inducible gene-1 γ or δ (RAE-1), ligands for the activating receptor NKG2D, the tumors were rejected. The tumor rejection was mediated by NK cells, and not by CD1-restricted NK1.1 + T cells. No T cell-mediated immunological memory against the parental tumor was generated in the animals that had rejected the RAE-1 transfected tumors, which succumbed to rechallenge with the parental RMA tumor. Therefore, NK cells are able to reject a tumor expressing RAE-1 molecules, despite expression of self MHC class I on the tumor, demonstrating the potential for NK cells to participate in immunity against class I-bearing malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NKG2D has been implicated in immune surveillance of tumors using transgenic models of spontaneous cancer as well as subcutaneous tumor transfer models (Cerwenka et al., 2001; Diefenbach et al., 2001; Guerra et al., 2008).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Cerwenka et al., 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Self-citationBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Self-citationCosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Self-citationBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Research works printed but not linked: 2
- 10.1146/annurev.iy.10.040192.001201 · doi:10.1146/annurev.iy.10.040192.001201 · Paper page
- S Bahram Adv Immunol 76, 1–60 (2000).
Cited by
Items 501–600 of 691
NK Cells and ILC1s in Cancer Biology
Sliz, A., & Yokoyama, W. M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8387-9_4 · Cited by 3
The Road from Mouse to Human ILCs: A Perspective of Understanding the Roles of ILCs in Disease
Spits, H. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8387-9_11 · Cited by 3
Pollock, R. A., Pellett, F., Chandran, V., & Gladman, D. D. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01764.x · Cited by 3
NK Cells in Antitumor Immunity
Cerwenka, A., & Pahl, J. H. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.17012-2 · Cited by 3
Self-citationWolf, N. K. (2022) · eScholarship (California Digital Library) · Cited by 3
Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients
Alamri, A. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00670-2 · Cited by 2
Myers, Z. D., & Matosevic, S. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00980-y · Cited by 2
Gupta, R. K., & Gupta, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1065-2_31 · Cited by 2
Guevara-Patino, J. A., & Plaza-Rojas, L. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.01.017 · Cited by 2
Yang, Z., Li, J., Watanabe, H., Gao, F., Kawajiri, A., Koinuma, K., Sato, K., Okuyama, Y., Tayama, S., Iwakura, Y., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0598 · Cited by 2
Lanier, L. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3385 · Cited by 2
Self-citationResearch on the effects of CD137 signaling on the function of CD3−CD56+NK cells
Zhang, Y., Ju, S., & Shu, Y. (2009) · 南京医科大学学报:英文版 · doi:10.1016/s1007-4376(09)60019-8 · Cited by 2
Role of γδ T Lymphocytes in Cancer Immunosurveillance and Immunotherapy
Lança, T., Correia, D. V., & Silva‐Santos, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_13 · Cited by 2
NKG2D-Based Cancer Immunotherapy
Wu, J. D., & Wang, X. (2011) · InTech eBooks · doi:10.5772/23523 · Cited by 2
Studies on the antigenicity of the NKG2D ligand H60a in tumour cells
Yadav, D., Ngolab, J., Dang, N., & Bui, J. D. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03427.x · Cited by 2
Expression, purification and crystallization of the human UL16-binding protein ULBP1
Watson, A. A., Christou, C. M., & O’Callaghan, C. A. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.04.019 · Cited by 2
Levels of Soluble NKG2D Ligands and Cancer History in Patients Starting Hemodialysis
Nagai, K., Tawara, T., Usui, J., Ebihara, I., Ishizu, T., Kobayashi, M., Maeda, Y., Kobayashi, H., & Yamagata, K. (2022) · Frontiers in Nephrology · doi:10.3389/fneph.2022.875207 · Cited by 2
Natural killer cells in cancer
Höglund, P., & Ljunggren, H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00004-1 · Cited by 2
The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy
Lv, C., Yang, D., Zhang, D., Shen, J., Wang, Z., He, S., Meng, L., Song, J., & Zhao, J. (2023) · Journal of Immunology Research · doi:10.1155/2023/2623317 · Cited by 2
Prinz, P. U. (2011) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.12699 · Cited by 2
Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors
Chung, D. C., Elford, A. R., & Jacquelot, N. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.03.008 · Cited by 1
Wang, L., Ding, Y., Lv, H., Yang, Y., Chen, M., Shi, B., Ma, Z., Hu, L., Zhang, R., Wu, D., et al. (2025) · Antibody Therapeutics · doi:10.1093/abt/tbaf023 · Cited by 1
Fifty Years of Natural Killer Cells: Milestones and Future Horizons
Lundqvist, A., Wagner, A. K., Chambers, B. J., Dahlberg, C. I. M., Sundbäck, J., Cuapio, A., Alici, E., & Ljunggren, H. (2026) · Scandinavian Journal of Immunology · doi:10.1111/sji.70091 · Cited by 1
Camrelizumab exhibits dual specificity implications for antitumor immunity
Имянитов, Е. Н., Suladze, S. A., Peshkova, I. O., Tikhonov, A. A., & Buletov, D. A. (2026) · Head and neck tumors (HNT) · doi:10.17650/2222-1468-2025-15-4-41-51 · Cited by 1
Immune Response and Immunotherapy in Chronic Lymphocytic Leukemia
Huergo-Zapico, L., Ana, P., Contesti, J., Fernndez-Guizn, A., Acebes‐Huerta, A., Lpez-Soto, A., & Gonzalez, S. R. (2012) · InTech eBooks · doi:10.5772/27086 · Cited by 1
López‐Larrea, C., López‐Soto, A., & Gonzalez, S. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00005-3 · Cited by 1
NK Cells in Cancer Immunotherapy
Addou-Klouche, L. (2017) · InTech eBooks · doi:10.5772/intechopen.71217 · Cited by 1
CLEC5a-directed bispecific antibody for effective cellular phagocytosis
Kedage, V., Ellerman, D. A., Fei, M., Liang, W., Zhang, G., Cheng, E., Zhang, J., Chen, Y., Huang, H., Lee, W. P., et al. (2022) · mAbs · doi:10.1080/19420862.2022.2040083 · Cited by 1
(An)geborene Abwehrspieler: Natürliche Killerzellen
Reinberger, S. (2006) · Steinkopff eBooks · doi:10.1007/3-7985-1639-1_13 · Cited by 1
Pardoll, D. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50009-9 · Cited by 1
Kshersagar, J. R., Bedge, P., Jagdale, R., Desai, S., Tardalkar, K. R., Jagadale, S., Jadhav, D. S., Toro, Y., & Joshi, M. G. (2022) · Annals of Cancer Research and Therapy · doi:10.4993/acrt.30.131 · Cited by 1
Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy
Harlan, L. M., & Djeu, J. Y. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:045 · Cited by 1
Okeke, O. I. (2025) · Mspace (University of Manitoba) · Cited by 1
Characterisation of CD8neg and CD8+ human natural killer cell subsets
Abdalla, I. I. I. (2012) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Regulation and Heterogeneity of Pancreatic Natural Killer Cells During Type 1 Diabetes
Sitrin, J. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Molecular specificities of NK cell-mediated recognition of human tumor cells
Carlsten, M. (2010) · Figshare · Cited by 1
Gupta, N. (2013) · doi:10.21007/etd.cghs.2013.0120 · Cited by 1
The role of the microenvironment and inflammation in the promotion of cancer metastasis
Arif, A. A. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0366205 · Cited by 1
Busche, A., Goldmann, T., Naumann, U., Steinle, A., & Brandau, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.17.ft-164 · Cited by 2
Hu, H., Chu, Y., & Urba, W. J. (2005) · Cancer treatment and research · doi:10.1007/0-387-27545-2_9 · Cited by 1
Semeraro, M. (2013) · theses.fr (ABES) · doi:10.70675/215d1a18z5598z4bc3zbc57z9fb4e3ac997c · Cited by 1
Importance des glycosaminoglycanes de surface dans les phénomènes inflammatoires liés au cancer
Martinez, P. (2014) · theses.fr (ABES) · doi:10.70675/d8d46778ze3baz4df0z9270z4a2656f165d0 · Cited by 1
Chauvin, C. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Immune suppression in multiple myeloma : strategies to overcome NK cell inhibition
Giunti, G. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Natural Killer Cells in the Treatment of Human Cancer
Malmberg, K., & Ljunggren, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-02309-5_22
Genetic and Expression Analyses of the 'Nkrp1-Clr' Gene Cluster
Zhang, Q. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6003
Hu, J. (2012) · Digital Commons-TMC (Texas Medical Center)
Natural killer cells in cancer : studies on migration and cytotoxicity
Wennerberg, E. (2014) · Figshare
Strategies for exploiting the immune system to achieve prevention and improve therapy of cancer
Hamilton, D. H. (2007) · University Library - University of Saskatchewan (University of Saskatchewan)
HLA Class I Antigen Abnormalities in Tumors
Seliger, B., & Ferrone, S. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_6
Intercellular protein transfer and regulation of inhibitory NK receptor accessibility
Andersson, K. (2007) · Figshare
Nowbakht, P. (2005) · edoc (University of Basel) · doi:10.5451/unibas-003679595
NK CELL RECOGNITION OF HERPESVIRUSES – MECHANISMS OF VIRAL IMMUNE ESCAPE
Rölle, A. (2008) · Figshare · doi:10.13140/2.1.1557.5365
Humanized mice as a model to study human immunity
Heuts, F. W. H. (2012) · Figshare
Development of natural killer cells regulated by T-box transcription factors
Gordon, S. M. (2011) · ScholarlyCommons (University of Pennsylvania)
Expression of ligands for the NKG2D activating receptor are linked to proliferative signals (108.2)
Jung, H., & Raulet, D. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.186.supp.108.2
Rajeshwar, K., & Shankar, H. (2009) · TigerPrints (Clemson University)
Mechanisms of Rejection of High Grade B cell Lymphoma in Mice
Sukumar, M. (2008) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10613
Influence of Ly49 inhibitory receptors and MHC class I on T cell and NK cell function
Öberg, L. (2005) · Figshare
Morales‐Ruíz, T. (2011) · Institutional Repository of the University of Granada (University of Granada)
Mechanisms underlying innate immunesenescence
Hazeldine, J. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham)
Allgeier, T. (2007) · Site cant be reached · doi:10.5282/edoc.7361
Virus Interactions with NK Cell Receptors
Lisnić, V. J., Gašparović, I., Krmpotić, A., & Jonjić, S. (2009) · Springer eBooks · doi:10.1007/978-3-642-02309-5_6
Effects of cigarette smoke on killer cell activation in chronic obstructive pulmonary disease
Wang, J. (2015) · Nottingham ePrints (University of Nottingham)
Update on vaccines for melanoma patients
Russo, V. E. A., Maccalli, C., Pilla, L., Mercuri, S. R., Orsenigo, E., Mukenge, S., Bregni, M., & Parmiani, G. (2008) · Expert Review of Dermatology · doi:10.1586/17469872.3.2.195
Ogasawara, K. (2005) · Journal of Oral Biosciences · doi:10.2330/joralbiosci.47.1
Bell, É. (2001) · Nature reviews. Immunology · doi:10.1038/35100537
Expression of RAE-1, a ligand of the NKG2D Receptor, in Mice Adipocytes
Iizumi, K., Tatemichi, M., & Nakadate, T. (2011) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms.23.181
Schafer, J. L. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
TRIGGERING AND MECHANISMS OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY
Bryceson, Y. T. (2008) · Figshare
Therapeutic potential of natural killer cells in multiple myeloma
Alici, E. (2006) · Figshare
Potenciació de la citotoxicitat cel·lular induïda pel Rituximab en cèl·lules B de LLC
Moga, E., & Esther, M. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Innate and adaptive immune responses in viral and chronic inflammatory diseases
Schepis, D. (2009) · Figshare
CellsSurveillance of Unhealthy Cells by Natural Killer
Iannello, A., & Raulet, D. H. (2013)
Calorie Restriction, Exercise, and Colon Cancer Prevention: A Mechanistic Perspective
Rogers, C. J., Colbert, L. H., Perkins, S. N., & Hursting, S. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7551-5_5
Understanding the Mechanism of Stimulatory NK-cell Ligand Expression
Tokuyama, M. (2012) · eScholarship (California Digital Library)
Myeloid-Derived Suppressor Cells in Tumor Immunology
Mundy-Bosse, B. L. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Role of the NKG2D Receptor in Health and Disease
Burgess, S. J., Narayanan, S., Borrego, F., & Coligan, J. E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-512-5_28
The Critical Role of PI3K-AKT-mTOR Pathway for IL-15 Induced NK Cell Effector Responses
Nandagopal, N. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3860
Mechanisms of early immune activation in response to hepatitis B virus.
Vilarinho, S. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/fkfa-fp52
NKG2D-vermittelte Lymphozytenaktivierung
Becker, J. C., Schrama, D., & L�hder, F. (2004) · Der Onkologe · doi:10.1007/s00761-004-0753-9
Transcription Factors Expression in NK and T Cells by Ap-1 Regulation of Human DAP10 Gene
Borrego, F., Coligan, J. E., Marusina, A. I., Burgess, S., & Pathmanathan, I. (2013)
Jänner, N. (2007) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15623
Natural killer cells and acute myeloid leukaemia
Stringaris, K. (2012) · doi:10.25560/18014
The interactions of human Natural Killer cells with accessory cells
Evans, J. H. (2011) · doi:10.25560/6374
Role of hypoxia and hypoxia-inducible factor-1 in tumour immune escape
Li, X. (2010) · QSpace (Queen's University Library)
MOLECULAR SIGNATURE OF TUMOR INFILTRATING NATURAL KILLER CELLS
Stojanovic, A. (2010) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00010979
Role of Nitric Oxide-Signalling in Hypoxia-Induced Immune Escape in Cancer
Hamilton, T. K. (2011) · QSpace (Queen's University Library)
Vokhminova, D. (2010) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00011233
Human Innate Lymphoid Cell Development
Scoville, S. D. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Mignot, G. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Mayes, K. (2017) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/3tb4-qf57
Durán, G. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Killer cell immunoglobulin-like receptor(KIR)遺伝子領域の構造,ハプロタイプ,及び多型に関する解析
Geraghty, D. E. (2003) · Major Histocompatibility Complex · doi:10.12667/mhc.10.33
Bandlamudi, C. (2016) · Knowledge@UChicago (University of Chicago) · doi:10.6082/k2g00-0se24
Metadata
- Authors
- Cerwenka, A., Baron, J. L., & Lanier, L. L.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-09-18
- Volume
- 98
- Issue
- 20
- Pages
- 11521-11526
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC58762
- OpenAlex
- W2056645320
- Cited by
- 606
- References
- 34
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 15 · 2020: 24 · 2019: 17 · 2018: 15 · 2017: 26 · 2016: 14 · 2015: 22 · 2014: 27 · 2013: 25 · 2012: 24
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- National Institutes of Health
- National Cancer Institute (CA89189, R01CA089189)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- Rae1, NKG2D, natural killer cells, MHC class I, tumor rejection, missing self, NK cell receptors, immune surveillance, NK1.1+ T cells, tumor rechallenge
- MeSH terms
- Animals, B-Lymphocytes, Female, Immunoglobulin Fc Fragments, Immunologic Memory, Killer Cells, Natural, Lymphocyte Depletion, Lymphoma, Major Histocompatibility Complex, Membrane Proteins, Mice, Inbred C57BL, Recombinant Fusion Proteins, Transfection, Tumor Cells, Cultured, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.